Abstract
Disseminated intravascular coagulation (DIC) is a serious clinical condition, but its pathophysiology is very different according to the underlying diseases responsible for DIG, For example, a marked activation of the coagulation and fibrinolytic system is present in most cases of acute promyelocytic leukemia. On the contrary, a little activation of the fibrinolytic system is present in most cases of sepsis with DIC1–4. Therefore, it is important to investigate these pathologic condithions separately according to the underlying disease responsible for DIC.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Takahashi H., Hanano M., Takizawa S., Tatewaki S. and Shibata A. (1988) Plasmin-α2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation. Am J Haematol 28:162–166.
Matsuda T., Asakura IL, Ito K., Saito M., Jokaji H., Uotani C. and Kumabashiri I. (1988) Changes in levels of t-PA and α2PI-plasmin complex in plasma in patients with DIC. Thromb Res [Suppl] 7:143–151.
Asakura H., Saito M., Ito K., Jokaji H., Uotani C., Kumabashiri I. and Matsuda T. (1988) Levels of thrombin-antithrombin III complex in plasma in cases of acute promyelocytic leukemia. Thromb Res 50:895–899.
Asakura H., Jokaji H., Saito M., Uotani C., Kumabashiri I., Morishita E., Yamazaki M. and Matsuda T. (1991) Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasmingen activator inhibitor in patients with disseminated intravascular coagulation. Am J Haematol 36: 176–183
Esmon C.T. and Owen W.G. (1981) Identification of an entothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 78:2249–2252
Salem H.H., Mruyama I., Ishii H. and Majerus P.W. (1984) Isolation and characterization of thrombomodulin from human placenta. J Biol Chem 259:12246–12251.
Ishii H. and Majerus P.W. (1985) Thrombomodulin is present in human plasma and urine. J Clin Invest 76:2178–2181.
Takano S., Kimura S., Ohdama S. and Aoki N. (1990) Plasma thrombomodulin in health and diseases. Blood 76:2024–2029.
Kruithof E.K.O, Tran T.C., Ransijn A. and Bachmann (1984) Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 64:907-
Sakata Y., Murakami T., Noro A., Mori K. and Matsuda M. (1991) The specific activity of plasminogen activator inhibitor- 1 in disseminated intravascular coagulation with acute promyelocytic leukemia. Blood 77:1949–1957
Kabayashi N., Maekawa T., Takada M. et al (1983) Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan. Bibliotheca Haematologica 49:265–275
Pelzer H., Schwarz A. and Heimburger N. (1988) Determination of human thrombin-antithrombin III complex in plasma with an enzyme—linked immunosorbent assay. Thromb Haemost 59:101–106.
Mimuro J., Koike Y., Sumi Y. and Aoki N. (1987) Monoclonal antibodies to discrete regions in α2-plasmin inhibitor. Blood 69:446–453.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Japan
About this paper
Cite this paper
Asakura, H. et al. (1992). Plasma Levels of Thrombomodulin and Active Plasminogen Activator Inhibitor Increase in Disseminated Intravascular Coagulation with Multiple Organ Failure. In: Takada, A., Budzynski, A.Z. (eds) Hemostasis and Circulation. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66925-8_33
Download citation
DOI: https://doi.org/10.1007/978-4-431-66925-8_33
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-70096-8
Online ISBN: 978-4-431-66925-8
eBook Packages: Springer Book Archive